Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.

Autor: Tavares ACFMG; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., de Melo AKG; Hospital Universitário Lauro Wanderley, Universidade Federal da Paraíba, R. Tab. Stanislau Eloy, 585 - Castelo Branco, João Pessoa, Paraíba, 58050-585, Brazil. anakarlagmelo@gmail.com., Cruz VA; Hospital das Clínicas, Universidade Federal de Goiás, Goiânia, Brazil., de Souza VA; Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil., de Carvalho JS; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Machado KLLL; Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo, Vitória, Brazil., de Azevedo Valadares LD; Hospital Getúlio Vargas, Recife, Brazil., Dos Reis Neto ET; Universidade Federal de São Paulo, São Paulo, Brazil., de Rezende RPV; Universidade Federal Fluminense, Niterói, Brazil., de Resende Guimarães MFB; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Ferreira GA; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., de Sousa Braz A; Hospital Universitário Lauro Wanderley, Universidade Federal da Paraíba, R. Tab. Stanislau Eloy, 585 - Castelo Branco, João Pessoa, Paraíba, 58050-585, Brazil., de Abreu Vieira RMR; Hospital Geral, Fortaleza, Brasil., de Medeiros Pinheiro M; Universidade Federal de São Paulo, São Paulo, Brazil., Ribeiro SLE; Universidade Federal do Amazonas, Manaus, Brazil., Bica BEGR; Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Baptista KL; Universidade Federal Fluminense, Niterói, Brazil., da Costa IP; Faculdade de Medicina, Universidade Federal do Mato Grosso do Sul, Campo Grande, Brazil., Marques CDL; Universidade Federal de Pernambuco, Recife, Brazil., Lopes MLL; Universidade Federal de Ciências da Saúde, Porto Alegre, Brazil., Martinez JE; Pontifícia Universidade Católica, São Paulo, Brazil., Giorgi RDN; Instituto de Assistência Médica ao Servidor Público Estadual, São Paulo, Brazil., da Mota LMH; Hospital Universitário, Brasília, Brazil., da Rocha Loures MAA; Universidade Estadual, Maringá, Brazil., Dos Santos Paiva E; Hospital das Clínicas, Universidade Federal do Paraná, Curitiba, Brazil., Monticielo OA; Hospital das Clínicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Xavier RM; Hospital das Clínicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Kakehasi AM; Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Pileggi GCS; Universidade Federal de São Paulo, São Paulo, Brazil.
Jazyk: angličtina
Zdroj: Advances in rheumatology (London, England) [Adv Rheumatol] 2022 Jan 17; Vol. 62 (1), pp. 3. Date of Electronic Publication: 2022 Jan 17.
DOI: 10.1186/s42358-022-00234-7
Abstrakt: Objective: To provide guidelines on the coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated rheumatic diseases (IMRD) to rheumatologists considering specific scenarios of the daily practice based on the shared-making decision (SMD) process.
Methods: A task force was constituted by 24 rheumatologists (panel members), with clinical and research expertise in immunizations and infectious diseases in immunocompromised patients, endorsed by the Brazilian Society of Rheumatology (BSR), to develop guidelines for COVID-19 vaccination in patients with IMRD. A consensus was built through the Delphi method and involved four rounds of anonymous voting, where five options were used to determine the level of agreement (LOA), based on the Likert Scale: (1) strongly disagree; (2) disagree, (3) neither agree nor disagree (neutral); (4) agree; and (5) strongly agree. Nineteen questions were addressed and discussed via teleconference to formulate the answers. In order to identify the relevant data on COVID-19 vaccines, a search with standardized descriptors and synonyms was performed on September 10th, 2021, of the MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and LILACS to identify studies of interest. We used the Newcastle-Ottawa Scale to assess the quality of nonrandomized studies.
Results: All the nineteen questions-answers (Q&A) were approved by the BSR Task Force with more than 80% of panelists voting options 4-agree-and 5-strongly agree-, and a consensus was reached. These Guidelines were focused in SMD on the most appropriate timing for IMRD patients to get vaccinated to reach the adequate covid-19 vaccination response.
Conclusion: These guidelines were developed by a BSR Task Force with a high LOA among panelists, based on the literature review of published studies and expert opinion for COVID-19 vaccination in IMRD patients. Noteworthy, in the pandemic period, up to the time of the review and the consensus process for this document, high-quality evidence was scarce. Thus, it is not a substitute for clinical judgment.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: